A detailed history of Clearstead Advisors, LLC transactions in Globus Medical Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 372 shares of GMED stock, worth $31,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
372
Previous 372 -0.0%
Holding current value
$31,586
Previous $25,000 4.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$49.79 - $68.85 $16,032 - $22,169
322 Added 644.0%
372 $25,000
Q4 2021

Feb 14, 2022

SELL
$62.62 - $79.92 $23,732 - $30,289
-379 Reduced 88.34%
50 $4,000
Q3 2021

Nov 12, 2021

BUY
$76.41 - $84.06 $28,959 - $31,858
379 Added 758.0%
429 $33,000
Q3 2020

Nov 12, 2020

BUY
$45.26 - $57.82 $2,263 - $2,891
50 New
50 $2,000

Others Institutions Holding GMED

About GLOBUS MEDICAL INC


  • Ticker GMED
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 77,037,200
  • Market Cap $6.54B
  • Description
  • Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...
More about GMED
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.